May 24, 2021
Moderated by Sec. Harry Roque:
Balitang IATF po muna tayo. Inaprubahan po ng inyong IATF noong Sabado, May 22 ang paglalagay sa Iloilo City sa Modified Enhanced Community Quarantine (MECQ) na nagsimula kahapon, May 23 at tatagal hanggang May 31.
Nasa ilalim din ng MECQ ang Apayao, Benguet, Cagayan hanggang May 31, 2021.
Usaping bakuna naman po tayo. Mahigit 4 na milyon o 4,097,425 na po na doses ang na-administer ng COVID-19 vaccine as of May 23,2021.
Nasa 162,514 po ang ating daily rate of doses administered base sa 7-day average as of May 23,2021.
Malaki na po ang itinaas ng ating 7-day Moving Average of Vaccinated Individuals na nagrehistro ng 32,940 noong Marso 30. Ito ay pumalo sa 35,320 noong Abril 27. Noong May 4 naman po ay 36,491, 67,780 noong May 11 at noong May 18 ay may 108,540.
Kung titignan ang absolute numbers, pang-37 ang Pilipinas sa 196 countries na nag-administer ng COVID-19 vaccines.
No. 13 po tayo sa Asya at pagdating po sa ASEAN tayo po ay pumapangalawa lamang po sa Indonesia.
(audio inaudible) ...Ang AstraZeneca ay may 70.4% vaccine efficacy based on Phase III Clinical Trial (CT) against symptomatic COVID-19 at 100% against severe COVID-19.
Ang Sputnik V ay 91.6% against symptomatic COVID-19 at 100% against moderate or severe cases.
Ang Sinovac, ay noong mga unang pag-aaral po ay between 65-91% base sa pag-aaral sa Brazil, Indonesia, at Turkey pero may bago pong pag-aaral no? Sa isang pag-aaral po ng isang unibersidad sa Thailand ay napag-alaman po na 99.49% na mga nakatanggap, 4 na linggo matapos matanggap nila ang ikalawang dose (ng Sinovac) ay nagkaroon ng antibody responses.
Samantala, nasa 66% na mga taong nakatanggap ng first dose, tatlong linggo ang nakararaan ay nagkaroon ng immune responses.
Nasa 13.9 million ang buong popoulasyon ng NCR. Nasa 70% o 9.7 million ang target nating mabakunahan. Ang ibig sabihin nito ay kinakailangan nating magpabakuna o makapagbakuna ng 108,000 kada araw hanggang November 27, 2021.
Dr. Rabindra Abeyasinghe - Representative to the Philippines, WHO:
Let me clarify the COVAX Facility committed to provide vaccines to cover 20% of the Philippine population.
That 20% of the population was determined to be the frontline healthcare workers and the elderly population, and the reason for that is this prioritization is based on WHO recommendations so that COVAX Facility vaccines are used to maximize the impact on the pandemic by reducing death and to ensure that the frontline health workers are actually protected.
While recognizing the other groups are important, it's clearly defined the largest number of deaths, severe cases are from A2 elderlies. We continue to urge national, local government's to follow prioritization to maximize the impact of donated vaccines.
We've completed the review of Sinopharm, it's now listed as a WHO-listed EUL product. WHO has sought clarification from Sinovac's manufacturer, we await that information.
We believe in the next few weeks that once that clarification is received, WHO will be able to reach a conclusion about listing Sinovac as a possible EUL candidate.
From the point of view of preventing severe disease and death, all of the vaccines the WHO has listed under EUL are capable of doing it.
Dr. Edsel Salvaña - Technical Advisory Group Member, DOH:
It's important we remember all vaccines with EUA are very effective against severe disease, which is the most important outcome for all our vaccines. Alam naman natin ang COVID ay 10 to 20 times more deadly than the flu.
So, in terms of vaccines from a scientific standpoint, the best vaccine you can get is the one that's there already. If you wait for your preferred brand, 'di na mag-hintay ang virus bago ka ma-infect. If you'll get infected, you can die.
As long as alam naman ng tao kung ano yung ituturok sa kaniya before iturok sa kaniya, I think that's enough. Pwede naman siya mag-refuse at that point.
Safe at effective naman po lahat ng bakuna and we urge everyone to get whatever vaccine's there because they all work.